- Report
- November 2020
- 286 Pages
Global
From €3142EUR$3,500USD£2,676GBP
- Report
- September 2023
- 168 Pages
Global
From €4175EUR$4,650USD£3,555GBP
- Report
- September 2023
- 160 Pages
Global
From €4175EUR$4,650USD£3,555GBP
- Report
- June 2022
- 117 Pages
Global
From €4938EUR$5,500USD£4,205GBP
- Report
- July 2022
- 215 Pages
Global
From €3816EUR$4,250USD£3,250GBP
- Report
- May 2023
- 102 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- October 2023
- 87 Pages
Global
From €4444EUR$4,950USD£3,785GBP
- Report
- April 2022
- 30 Pages
Global
From €2200EUR$2,450USD£1,873GBP
- Report
- September 2023
- 100 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- February 2024
- 175 Pages
Global
From €4489EUR$5,000USD£3,823GBP
- Report
- May 2024
- 187 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- April 2024
- 180 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- February 2024
- 187 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- February 2023
- 73 Pages
United States
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP
- Report
- December 2022
- 85 Pages
Asia Pacific
From €3053EUR$3,400USD£2,600GBP
€3591EUR$4,000USD£3,058GBP
- Report
- July 2022
- 115 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- May 2022
- 116 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- February 2024
- 114 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2023
- 68 Pages
Japan
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2023
- 89 Pages
Saudi Arabia
From €4265EUR$4,750USD£3,632GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more